Myelofibrosis is a chronic condition in which scar tissue builds up in the bone marrow, interfering with its ability to produce healthy blood cells. It can lead to severe anemia, fatigue, an enlarged spleen, frequent infections, and a higher risk of developing leukemia. Because of its complexity and potential progression, myelofibrosis should be managed by a specialist with extensive experience in hematologic malignancies.
Dr. S.K. Gupta, a highly respected hematologist and hemato-oncologist, is known for his excellence in diagnosing and treating rare blood disorders such as myelofibrosis. His approach combines the latest medical advancements with a patient-first philosophy, ensuring individuals receive personalized and comprehensive care at every stage of their treatment.
Patients who visit [Hospital Name] for myelofibrosis under Dr. S.K. Gupta’s care benefit from:
- Accurate diagnosis using advanced blood tests, bone marrow biopsy, genetic testing, and imaging
- Personalized treatment plans based on disease stage, symptoms, and genetic markers
- Targeted therapies and JAK inhibitors such as ruxolitinib and fedratinib to reduce spleen size and improve quality of life
- Supportive treatments for anemia and symptom management, including blood transfusions and iron chelation therapy
- Stem cell transplantation for eligible patients, offering potential for long-term remission or cure
- Continuous monitoring to manage symptoms and assess disease progression
What sets Dr. S.K. Gupta apart is his ability to stay at the forefront of medical research while maintaining a warm, empathetic relationship with his patients. He ensures that individuals with myelofibrosis understand their diagnosis, treatment options, and prognosis, enabling them to make informed decisions about their care.